2020
Vivet Therapeutics: FDA approved fase 1/2 study for VTX-801
19/11/2020PARIS / NEW YORK. November 2020 — Vivet Therapeutics, a gene therapy biotech company dedicated to developing treatments for inherited liver... Read More
Viralgen is awarded the “Radio San Sebastián Excellence Award”
17/11/2020San Sebastián. November 2020 - Viralgen was awarded the Radio San Sebastián Excellence Award at the Kursaal Congress Centre in San... Read More
Viralgen has received the DonostiaINN 2020 Award in San Sebastian
02/11/2020San Sebastián. Noviembre 2020 - Viralgen has received the DonostiaINN 2020 Award in the 'young innovative companies' category, from Fomento de... Read More
The 4 divestments from the Columbus VP Fund accumulate an IRR of 130%
28/10/2020Valencia | Madrid. October 2020 - Columbus Venture Partners, a Spanish-owned venture capital firm in the biotechnology sector, has announced the... Read More
Bayer boosts its gene therapy platform
28/10/2020San Sebastian, Spain. October 2020- The Basque company Viralgen, the first production site in Spain dedicated to the production of adeno-associated... Read More
Bayer acquires Asklepios BioPharmaceutical for $4 billion
26/10/2020Germany. October 2020- Bayer has struck a deal to acquire Asklepios BioPharmaceutical for $2 billion upfront. The deal, which features an... Read More
BO-112 : Immunotherapie against cancer has completed its first research phase
22/10/2020BO-112, the first spanish immunotherapy has completed the first research phase in patients with immunotherapy-resistant cancer Read complete news here Read More
Algenex inaugurates the new facility to produce vaccines
26/09/2020The new facility can support the production of up to 3.5kg of recombinant protein equivalent to around 100 million vaccine doses... Read More
Vivet and Pfizer: Gene Therapy for Wilson Disease
24/09/2020PARIS- NEW YORK,—September 23, 2020— Vivet Therapeutics, a privately held gene therapy biotech company dedicated to developing treatments for inherited liver... Read More
Axovant and Viralgen Sign Strategic Gene Therapy Partnership
16/09/2020NEW YORK and BASEL, Switzerland, Sept. 15, 2020 -- Axovant Gene Therapies Ltd (NASDAQ: AXGT), a clinical-stage company developing innovative gene... Read More